Trial Details

Not Recruiting
Basic Information
Clinical ID c5402
Identifier CTIS2024-514740-82-00
Trial Title Subcutaneous vedolizumab drug de-escalation in inflammatory bowel disease: a multicentre randomised controlled study - NL83430.172.01
Trial URL Visit Original Page
Study Information
Study Results

NULL
Conditions Inflammatory Bowel Disease MedDRA version: 20.0Level: PTClassification code: 10011401Term: Crohn's disease Class: 100000004856 MedDRA version: 20.0Level: PTClassification code: 10009900Term: Colitis ulcerative Class: 100000004856;Therapeutic area:
Interventions Product Name: Entyvio 108 mg solution for injection in pre-filled syringe, Product Code:PRD8036142, Pharmaceutical Form: SOLUTION FOR INJECTION, Other descriptive name: , Strength:
Participant Information
Sponsor Stichting Amsterdam UMC
City NULL
Country/Region Netherlands
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT
Study Design
Study Type Interventional clinical trial of medicinal product
Phase PHASE4
Time Information
Start Date NULL
Primary Completion Date NULL
Completion Date NULL